相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical and epidemiological features of myasthenia gravis in Chilean population
G. Cea et al.
ACTA NEUROLOGICA SCANDINAVICA (2018)
HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis
Y. Hong et al.
ACTA NEUROLOGICA SCANDINAVICA (2018)
Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis
Fang Li et al.
ANNALS OF HUMAN GENETICS (2018)
IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody
Bonnie E. Lonze et al.
ANNALS OF SURGERY (2018)
Challenging the current model of early-onset myasthenia gravis pathogenesis in the light of the MGTX trial and histological heterogeneity of thymectomy specimens
Cleo-Aron Weis et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Rationale for the clinical guidelines for myasthenia gravis in Japan
Hiroyuki Murai et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis
Min Yan et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Therapeutic strategies for congenital myasthenic syndromes
Manon Lee et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues
Melanie A. Cron et al.
AUTOIMMUNITY REVIEWS (2018)
Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases
Taylor Pindi Sala et al.
AUTOIMMUNITY REVIEWS (2018)
A nationwide epidemiological study of myasthenia gravis in Latvia
A. Zieda et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes
Pedro M. Rodriguez Cruz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Characteristics, incidence, and outcome of patients admitted to the intensive care unit with myasthenia gravis
Wisam Al-bassam et al.
JOURNAL OF CRITICAL CARE (2018)
Immunostick ELISA for rapid and easy diagnosis of myasthenia gravis
Nikolaos Trakas et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2018)
Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis
Liis Sabre et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Myasthenia gravis and infectious disease
Nils Erik Gilhus et al.
JOURNAL OF NEUROLOGY (2018)
Low specificity of voltage-gated calcium channel antibodies in Lambert-Eaton myasthenic syndrome: a call for caution
Rodica Di Lorenzo et al.
JOURNAL OF NEUROLOGY (2018)
Thymic tolerance as a key brake on autoimmunity
Mickie Cheng et al.
NATURE IMMUNOLOGY (2018)
Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis
Karen Hewett et al.
NEUROLOGY (2018)
Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice
Min Yan et al.
NEUROSCIENCE (2018)
Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis
Dan He et al.
ANNALS OF NEUROLOGY (2018)
Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
Justin C. Kao et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence
N. E. Gilhus et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
Peter Ulrichts et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature
Devis Benfaremo et al.
CURRENT DRUG SAFETY (2018)
The Association of British Neurologists' myasthenia gravis guidelines
Jon Sussman et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Diagnostic utility of cortactin antibodies in myasthenia gravis
Isabel Illa et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study
Silvia Bonanno et al.
SAGE OPEN MEDICINE (2018)
Circulating microRNAs as potential biomarkers in myasthenia gravis patients
Anna Rostedt Punga et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Myasthenia gravis with antibodies to MuSK: an update
Amelia Evoli et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Thymus involvement in early-onset myasthenia gravis
Melanie A. Cron et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Multiple antibody detection in 'seronegative' myasthenia gravis patients
Y. Hong et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort
T. H. Popperud et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2017)
Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis
Shuuichi Mori et al.
EXPERIMENTAL NEUROLOGY (2017)
Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice
Canan Ulusoy et al.
IMMUNOLOGICAL INVESTIGATIONS (2017)
IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients
Inga Koneczny et al.
JOURNAL OF AUTOIMMUNITY (2017)
Titin force enhancement following active stretch of skinned skeletal muscle fibres
Krysta Powers et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2017)
Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis
Konstantinos Lazaridis et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
被撤回的出版物: Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms (Retracted article. See vol. 266, pg. 1555, 2019)
Yu Hong et al.
JOURNAL OF NEUROLOGY (2017)
Intracellular calcium release channels: an update
Gaetano Santulli et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Eculizumab: a treatment option for mysthenia gravis?
Nils Erik Gilhus
LANCET NEUROLOGY (2017)
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
James F. Howard et al.
LANCET NEUROLOGY (2017)
PREVALENCE AND CLINICAL ASPECTS OF IMMIGRANTS WITH MYASTHENIA GRAVIS IN NORTHERN EUROPE
Marion Ingeborg Boldingh et al.
MUSCLE & NERVE (2017)
PHYSICAL EXERCISE IN MYASTHENIA GRAVIS IS SAFE AND IMPROVES NEUROMUSCULAR PARAMETERS AND PHYSICAL PERFORMANCE-BASED MEASURES: A PILOT STUDY
Elisabet Westerberg et al.
MUSCLE & NERVE (2017)
EXERCISE IN MYASTHENIA GRAVIS: A FEASIBILITY STUDY OF AEROBIC AND RESISTANCE TRAINING
Martin Amadeus Rahbek et al.
MUSCLE & NERVE (2017)
RITUXIMAB TREATMENT OF MYASTHENIA GRAVIS: A SYSTEMATIC REVIEW
Rup Tandan et al.
MUSCLE & NERVE (2017)
Subcutaneous immunoglobulin in myasthenia gravis exacerbation A prospective, open-label trial
Grayson Beecher et al.
NEUROLOGY (2017)
Resistant myasthenia gravis and rituximab: A monocentric retrospective study of 28 patients
Vadim Afanasiev et al.
NEUROMUSCULAR DISORDERS (2017)
Ephedrine treatment for autoimmune myasthenia gravis
Alexander F. Lipka et al.
NEUROMUSCULAR DISORDERS (2017)
Seronegative myasthenia gravis associated with malignant thymoma
Jason Richards et al.
NEUROMUSCULAR DISORDERS (2017)
Engineered clearing agents for the selective depletion of antigen-specific antibodies
Siva Charan Devanaboyina et al.
NATURE COMMUNICATIONS (2017)
Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications
Kaori Noridomi et al.
ELIFE (2017)
Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody-Positive Myasthenia Gravis
Kimberly R. Robeson et al.
JAMA NEUROLOGY (2017)
Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools
Tomohiro Makino et al.
PLOS ONE (2017)
Pathophysiology and immunological profile of myasthenia gravis and its subgroups
Fredrik Romi et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Effect of local cooling on excitation-contraction coupling in myasthenic muscle: Another mechanism of ice-pack test in myasthenia gravis
Daisuke Yamamoto et al.
CLINICAL NEUROPHYSIOLOGY (2017)
Pitfalls and errors in measuring jitter
Erik Stalberg et al.
CLINICAL NEUROPHYSIOLOGY (2017)
IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG
Saif Huda et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Survey of epidemiology, clinical picture and current treatments for elderly-onset (≥ 65 years) patients with myasthenia gravis in Nagano Prefecture, Japan
Yuka Ogawa et al.
NEUROLOGY AND CLINICAL NEUROSCIENCE (2017)
MORTALITY IN MYASTHENIA GRAVIS: A NATIONWIDE POPULATION-BASED FOLLOW-UP STUDY IN DENMARK
Julie S. Hansen et al.
MUSCLE & NERVE (2016)
Repetitive nerve stimulation often fails to detect abnormal decrement in acute severe generalized Myasthenia Gravis
Maarika Liik et al.
CLINICAL NEUROPHYSIOLOGY (2016)
Comparison of CT and chemical-shift MRI for differentiating thymoma from non-thymomatous conditions in myasthenia gravis: value of qualitative and quantitative assessment
A. M. Priola et al.
CLINICAL RADIOLOGY (2016)
Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis
A. V. Nikolic et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases
Nadine Dragin et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Incidence and Prevalence of Myasthenia Gravis in Korea: A Population-Based Study Using the National Health Insurance Claims Database
Su-Yeon Park et al.
JOURNAL OF CLINICAL NEUROLOGY (2016)
Titin antibodies in seronegative myasthenia gravis - A new role for an old antigen
C. Stergiou et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients
Yu Hong et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity
Maartje G. Huijbers et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Maintenance immunosuppression in myasthenia gravis
Lauren Gotterer et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
EFFICACY OF PREDNISONE FOR THE TREATMENT OF OCULAR MYASTHENIA (EPITOME): A RANDOMIZED, CONTROLLED TRIAL
Michael Benatar et al.
MUSCLE & NERVE (2016)
FACTORS AFFECTING OUTCOME IN MYASTHENIA GRAVIS
Jintana B. Andersen et al.
MUSCLE & NERVE (2016)
CHARACTERISTICS OF ACETYLCHOLINE-RECEPTOR-ANTIBODY-NEGATIVE MYASTHENIA GRAVIS IN A SOUTH AFRICAN COHORT
Saif Huda et al.
MUSCLE & NERVE (2016)
INTERNATIONAL CLINIMETRIC EVALUATION OF THE MG-QOL15, RESULTING IN SLIGHT REVISION AND SUBSEQUENT VALIDATION OF THE MG-QOL15R
Ted M. Burns et al.
MUSCLE & NERVE (2016)
Myasthenia gravis - autoantibody characteristics and their implications for therapy
Nils Erik Gilhus et al.
NATURE REVIEWS NEUROLOGY (2016)
Development and validation of the Myasthenia Gravis Impairment Index
Carolina Barnett et al.
NEUROLOGY (2016)
Ocular vestibular evoked myogenic potentials as a test for myasthenia gravis
Yulia Valko et al.
NEUROLOGY (2016)
Increased risk for clinical onset of myasthenia gravis during the postpartum period
Marion I. Boldingh et al.
NEUROLOGY (2016)
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis
Mamatha Pasnoor et al.
NEUROLOGY (2016)
International consensus guidance for management of myasthenia gravis: Executive summary
Donald B. Sanders et al.
NEUROLOGY (2016)
Enzymatic Activity of the Scaffold Protein Rapsyn for Synapse Formation
Lei Li et al.
NEURON (2016)
Myasthenia Gravis
Nils E. Gilhus
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Randomized Trial of Thymectomy in Myasthenia Gravis
G. I. Wolfe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation
Adam Bryant et al.
JAMA NEUROLOGY (2016)
Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up
Dustin Anderson et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study
P. R. Bourque et al.
PLOS ONE (2016)
Myasthenia gravis - diagnosis and treatment
Nils Erik Gilhus et al.
TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING (2016)
PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents
Kiran M. Kanth et al.
NEUROLOGY-CLINICAL PRACTICE (2016)
Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases
P. M. Rodriguez Cruz et al.
EXPERIMENTAL NEUROLOGY (2015)
Thymoma related myasthenia gravis in humans and potential animal models
Alexander Marx et al.
EXPERIMENTAL NEUROLOGY (2015)
MuSK autoantibodies in myasthenia gravis detected by cell based assay - A multinational study
A. I. Tsonis et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
MuSK Frizzled-Like Domain Is Critical for Mammalian Neuromuscular Junction Formation and Maintenance
Julien Messeant et al.
JOURNAL OF NEUROSCIENCE (2015)
Myasthenia gravis: subgroup classification and therapeutic strategies
Nils Erik Gilhus et al.
LANCET NEUROLOGY (2015)
Can mycophenolate mofetil be tapered safely in myasthenia gravis? A retrospective, multicenter analysis
Lisa D. Hobson-Webb et al.
MUSCLE & NERVE (2015)
Geographical Distribution of Myasthenia Gravis in Northern Europe - Results from a Population-Based Study from Two Countries
Marion I. Boldingh et al.
NEUROEPIDEMIOLOGY (2015)
A Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia Gravis
Donald B. Sanders et al.
NEUROTHERAPEUTICS (2015)
Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis
Pedro M. Rodriguez Cruz et al.
JAMA NEUROLOGY (2015)
The emerging role of tacrolimus in myasthenia gravis
Jennifer L. Cruz et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2015)
Robotic thymectomy in patients with myasthenia gravis: neurological and surgical outcomes
Marlies Keijzers et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2015)
Myasthenia gravis and risks for comorbidity
N. E. Gilhus et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients (vol 9, e108327, 2014)
G. Kordas et al.
PLOS ONE (2015)
Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries
J. B. Andersen et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Antititin antibody in early- and late-onset myasthenia gravis
P. Szczudlik et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Cortactin autoantibodies in myasthenia gravis
Eduard Gallardo et al.
AUTOIMMUNITY REVIEWS (2014)
Identification of a novel myositis-associated antibody directed against cortactin
Moises Labrador-Horrillo et al.
AUTOIMMUNITY REVIEWS (2014)
Myasthenia gravis: an update for the clinician
J. P. Sieb
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Is the decremental pattern in Lambert-Eaton syndrome different from that in myasthenia gravis?
D. B. Sanders et al.
CLINICAL NEUROPHYSIOLOGY (2014)
Treatment of MuSK-Associated Myasthenia Gravis
Khalid El-Salem et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2014)
Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine
E. G. Pedersen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Cardiac involvements in myasthenia gravis associated with anti-Kv1.4 antibodies
S. Suzuki et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Myasthenia and risk of cancer: a population-based case-control study
E. G. Pedersen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
EFNS/ENS Guidelines for the treatment of ocular myasthenia
E. Kerty et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis
J. S. Yi et al.
JOURNAL OF AUTOIMMUNITY (2014)
Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: Roles of IL-17 and TNF-α
Angeline Gradolatto et al.
JOURNAL OF AUTOIMMUNITY (2014)
Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms
Sonia Berrih-Aknin et al.
JOURNAL OF AUTOIMMUNITY (2014)
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
P. Zisimopoulou et al.
JOURNAL OF AUTOIMMUNITY (2014)
Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group
Fiona Norwood et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
HEALTH-RELATED QUALITY-OF-LIFE AND TREATMENT TARGETS IN MYASTHENIA GRAVIS
Kimiaki Utsugisawa et al.
MUSCLE & NERVE (2014)
Electrophysiological profile of the patients with MuSK positive myasthenia gravis
Ana Nikolic et al.
NEUROLOGICAL RESEARCH (2014)
Anti-agrin autoantibodies in myasthenia gravis
Christiane Gasperi et al.
NEUROLOGY (2014)
LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients
John S. Tzartos et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
Alexander Marx et al.
AUTOIMMUNITY REVIEWS (2013)
Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens
Paraskevi Zisimopoulou et al.
AUTOIMMUNITY REVIEWS (2013)
Complement associated pathogenic mechanisms in myasthenia gravis
Erdem Tuzun et al.
AUTOIMMUNITY REVIEWS (2013)
Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase
Amelia Evoli et al.
AUTOIMMUNITY REVIEWS (2013)
Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009
E. G. Pedersen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis
Chengyong Shen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The neuromuscular junction: Selective remodeling of synaptic regulators at the nerve/muscle interface
Veit Witzemann et al.
MECHANISMS OF DEVELOPMENT (2013)
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4
Maartje G. Huijbers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Nicotinic acetylcholine receptor and the structural basis of neuromuscular transmission: insights from Torpedo postsynapticmembranes
Nigel Unwin
QUARTERLY REVIEWS OF BIOPHYSICS (2013)
Introduction for Myasthenia Gravis and Related Disorders
Gil I. Wolfe et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS II (2012)
Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis
Bin Zhang et al.
ARCHIVES OF NEUROLOGY (2012)
Structural basis of agrin-LRP4-MuSK signaling
Yinong Zong et al.
GENES & DEVELOPMENT (2012)
The Nicotinic Acetylcholine Receptor: The Founding Father of the Pentameric Ligand-gated Ion Channel Superfamily
Jean-Pierre Changeux
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine
Konstantinos Poulas et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis
Fredrik Romi et al.
JOURNAL OF NEUROLOGY (2012)
Techniques and applications of EMG: measuring motor units from structure to function
Rachel C. Thornton et al.
JOURNAL OF NEUROLOGY (2012)
Mechanisms of Disease Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
Erwin W. Gelfand
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Lack of Evidence for Epstein-Barr Virus Infection in Myasthenia Gravis Thymus
Mandy Meyer et al.
ANNALS OF NEUROLOGY (2011)
Autoantibodies to Low-Density Lipoprotein Receptor-Related Protein 4 in Myasthenia Gravis
Osamu Higuchi et al.
ANNALS OF NEUROLOGY (2011)
A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis
Jeannine M. Heckmann et al.
BMC NEUROLOGY (2011)
Use of the Cogan Lid Twitch to Identify Myasthenia Gravis
Eric L. Singman et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2011)
Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis
Hiroaki Yoshikawa et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies
Maarten J. Titulaer et al.
LANCET NEUROLOGY (2011)
THE MG-QOL15 FOR FOLLOWING THE HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH MYASTHENIA GRAVIS
Ted M. Burns et al.
MUSCLE & NERVE (2011)
Utilizing Twins Concordance Rates to Infer the Predisposition to Myasthenia Gravis
Ryan Ramanujam et al.
TWIN RESEARCH AND HUMAN GENETICS (2011)
Current and emerging therapies for the treatment of myasthenia gravis
Renato Mantegazza et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2011)
Current and emerging treatments for the management of myasthenia gravis
Sivakumar Sathasivam
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2011)
Immunosuppressive therapies in myasthenia gravis
Donald B. Sanders et al.
AUTOIMMUNITY (2010)
A systematic review of population based epidemiological studies in Myasthenia Gravis
Aisling S. Carr et al.
BMC NEUROLOGY (2010)
Guidelines for treatment of autoimmune neuromuscular transmission disorders
G. O. Skeie et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Extrathymic malignancies in thymoma patients with and without myasthenia gravis
Jone Furlund Owe et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
MYCOPHENOLATE MOFETIL IN AChR-ANTIBODY-POSITIVE MYASTHENIA GRAVIS: OUTCOMES IN 102 PATIENTS
Michael K. Hehir et al.
MUSCLE & NERVE (2010)
The MG Composite A valid and reliable outcome measure for myasthenia gravis
Ted M. Burns et al.
NEUROLOGY (2010)
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Jane Hoyt Buckner
NATURE REVIEWS IMMUNOLOGY (2010)
Comparative Clinical Outcomes of Thymectomy for Myasthenia Gravis Performed by Extended Transsternal and Minimally Invasive Approaches
Dan M. Meyer et al.
ANNALS OF THORACIC SURGERY (2009)
Prednisolone Treatment Induces Tolerogenic Dendritic Cells and a Regulatory Milieu in Myasthenia Gravis Patients
Claudia Luther et al.
JOURNAL OF IMMUNOLOGY (2009)
Crystal Structure of the Frizzled-Like Cysteine-Rich Domain of the Receptor Tyrosine Kinase MuSK
Amy L. Stiegler et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Main Immunogenic Region Structure Promotes Binding of Conformation-Dependent Myasthenia Gravis Autoantibodies, Nicotinic Acetylcholine Receptor Conformation Maturation, and Agonist Sensitivity
Jie Luo et al.
JOURNAL OF NEUROSCIENCE (2009)
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Matthew N. Meriggioli et al.
LANCET NEUROLOGY (2009)
SEROPOSITIVE MYASTHENIA GRAVIS: A NATIONWIDE EPIDEMIOLOGIC STUDY
Anne Taraldsen Heldal et al.
NEUROLOGY (2009)
The Ice Pack Test in the Differential Diagnosis of Myasthenic Diplopia
Klio I. Chatzistefanou et al.
OPHTHALMOLOGY (2009)
Localization and mobility of the delayed-rectifer K+ channel Kv2.1 in adult cardiomyocytes
Kristen M. S. O'Connell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis
Daniel B. Drachman et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis
Maria Isabel Leite et al.
BRAIN (2008)
Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK
Natalie Kim et al.
CELL (2008)
The ageing and myasthenic thymus: A morphometric study validating a standard procedure in the histological workup of thymic specimens
Philipp Stroebel et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Disease-specific measure of quality of life for myasthenia gravis
Larry L. Mullins et al.
MUSCLE & NERVE (2008)
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis
D. B. Sanders et al.
NEUROLOGY (2008)
CD4+ CD25+ FoxP3+ regulatory T cells in autoimmune diseases
Xavier Valencia et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus
Matthieu Giraud et al.
NATURE (2007)
A prospective study assessing the utility of Cogan's lid twitch sign in patients with isolated unilateral or bilateral ptosis
Gregory P. Van Stavern et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG)
Vered Molina et al.
AUTOIMMUNITY (2006)
Sleep apnea in patients with myasthenia gravis
M. W. Nicolle et al.
NEUROLOGY (2006)
Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001
JF Owe et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Striational antibodies in myasthenia gravis - Reactivity and possible clinical significance
F Romi et al.
ARCHIVES OF NEUROLOGY (2005)
Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG
MI Leite et al.
ANNALS OF NEUROLOGY (2005)
Efficacy of low-dose FK506 in the treatment of myasthenia gravis - A randomized pilot study
Y Nagane et al.
EUROPEAN NEUROLOGY (2005)
Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis
LG De Feo et al.
MUSCLE & NERVE (2002)
Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire
L Padua et al.
NEUROLOGICAL SCIENCES (2002)
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
W Hoch et al.
NATURE MEDICINE (2001)
Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
GS Gronseth et al.
NEUROLOGY (2000)
Myasthenia gravis - Recommendations for clinical research standards
A Jaretzki et al.
NEUROLOGY (2000)
分享论文
